Skip to content

Phase 1 Study of AZD9833 Alone or in Combination in Women with Advanced Breast Cancer

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-506890-37-00
Acronym
D8530C00001
Enrollment
173
Registered
2024-04-29
Start date
2019-03-01
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

"Estrogen Receptor Positive HER2 Negative Advanced Breast Cancer"

Interventions

None listed

Sponsors

Astrazeneca AB
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026